(Hypertension. 2002;39:838.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Cardiovascular Medicine (H.M., N.I., T.A, M.O., S.U., T.S., T.A., Y.H., RN), Department of Nephrology and Metabolic Diseases (M.N.), University of Tokyo Graduate School of Medicine, Tokyo, Japan; and Department of Pathology, Wakayama Medical University (I.M., Y.N., MS) Wakayama, Japan.
Correspondence to Nobukazu Ishizaka, MD, PhD, Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail nobuishizka-tky{at}umin.ac.jp
The klotho gene, originally identified by insertional mutagenesis in mice, suppresses the expression of multiple aging-associated phenotypes. This gene is predominantly expressed in the kidney. Recent studies have shown that expression of renal klotho gene is regulated in animal models of metabolic diseases and in humans with chronic renal failure. However, little is known about the mechanisms and the physiological relevance of the regulation of the expression of the klotho gene in the kidney in some diseased conditions. In the present study, we first investigated the role of angiotensin II in the regulation of renal klotho gene expression. Long-term infusion of angiotensin II downregulated renal klotho gene expression at both the mRNA and protein levels. This angiotensin II-induced renal klotho downregulation was an angiotensin type 1 receptor-dependent but pressor-independent event. Adenovirus harboring mouse klotho gene (ad-klotho, 3.3x1010 plaque forming units) was also intravenously administered immediately before starting angiotensin II infusion in some rats. This resulted in a robust induction of Klotho protein in the liver at day 4, which was still detectable 14 days after the gene transfer. Ad-klotho gene transfer, but not ad-lacZ gene transfer, caused an improvement of creatinine clearance, decrease in urinary protein excretion, and amelioration of histologically demonstrated tubulointerstitial damage induced by angiotensin II administration. Our data suggest that downregulation of the renal klotho gene may have an aggravative role in the development of renal damage induced by angiotensin II, and that induction of the klotho gene may have therapeutic possibilities in treating angiotensin II-induced end organ damage.
Key Words: aging angiotensin II gene regulation renal disease hypertension, experimental
This article has been cited by other articles:
![]() |
Y. Wang and Z. Sun Klotho Gene Delivery Prevents the Progression of Spontaneous Hypertension and Renal Damage Hypertension, October 1, 2009; 54(4): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugiura, T. Yoshida, M. Mitobe, S. Yoshida, S. Shiohira, K. Nitta, and K. Tsuchiya Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70 Nephrol. Dial. Transplant., September 10, 2009; (2009) gfp451v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, V. Di Giovanni, N. He, K. Wang, A. Ingram, N. D. Rosenblum, and Y. Pei Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks Hum. Mol. Genet., July 1, 2009; 18(13): 2328 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Cha, M.-C. Hu, H. Kurosu, M. Kuro-o, O. Moe, and C.-L. Huang Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by Klotho Mol. Pharmacol., July 1, 2009; 76(1): 38 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsuruoka, K. Nishiki, T. Ioka, H. Ando, Y. Saito, M. Kurabayashi, R. Nagai, and A. Fujimura Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2762 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugiura, T. Yoshida, K. Tsuchiya, M. Mitobe, S. Nishimura, S. Shirota, T. Akiba, and H. Nihei Klotho reduces apoptosis in experimental ischaemic acute renal failure Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2636 - 2645. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, N. Ishizaka, T. Aizawa, M. Sata, N. Iso-o, E. Noiri, I. Mori, M. Ohno, and R. Nagai Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-{beta}1 in the heart Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1836 - H1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Arking, G. Atzmon, A. Arking, N. Barzilai, and H. C. Dietz Association Between a Functional Variant of the KLOTHO Gene and High-Density Lipoprotein Cholesterol, Blood Pressure, Stroke, and Longevity Circ. Res., March 4, 2005; 96(4): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Narumiya, S. Sasaki, N. Kuwahara, H. Irie, T. Kusaba, H. Kameyama, K. Tamagaki, T. Hatta, K. Takeda, and H. Matsubara HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells Cardiovasc Res, November 1, 2004; 64(2): 331 - 336. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |